PMI falls to 56.6% in March

The production sector's labor component rose to 60.1% from 56.2%.

By DANIEL KENNEMER
April 25, 2006 07:50

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Dun & Bradstreet Israel said the purchasing managers index (PMI) fell 1.2 percentage points to 56.6 percent in March, from 57.8% in February, indicating slower expansion in Israel's production sector. Values above 50% indicate growth. March's reduced expansion rate was attributed primarily to a sharp decline in domestic demand, which fell to 51% from 58.7% in February and forced Israeli factories to reduce production outputs (whose index component slipped to 60.1% from 61.5%), despite a rise in export demand to 64% from 60.5%. The production sector's labor component rose to 60.1% from 56.2%.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS